Kate received her Bachelor of Science degree from Duke University in 2005.  She received her MD from Harvard Medical School.  Kate is interested in using disease modeling and decision analysis to evaluate cancer screening and treatment strategies.

• Annual screening strategies in BRCA1 and BRCA2 gene mutation carriers: A comparative effectiveness analysis.

• Cost-effectiveness of MRI Screening in BRCA Gene Mutation Carriers
• Lung Cancer Policy Model